Extracellular Hsp90 has also been shown to promote cell motility in an ERK and MMP2-dependent manner and promote a mesenchymal phenotype in prostate cancer cells (Hance et al., 2012; Wang et al., 2019). Here, HSP90AB1 is linked to prostate carcinoma.